The BET family proteins including BRD2, BRD3, and BRD4 have recently been identified as SPOP substrates and the elevation of these proteins due to hotspot mutations in SPOP confers BET inhibitor resistance in PCa (Dai et al, 2017; Zhang et al, 2017). The gene discussed is BRD4; the disease is posterior cortical atrophy.